Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Merrimack Pharmaceuticals...

    NASDAQ: MACK · Real-Time Price · USD
    15.14
    0.01 (0.07%)
    At close: May 17, 2024, 9:59 PM

    Merrimack Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -1.18M -1.54M -2.46M
    Depreciation & Amortization
    		 n/a n/a n/a
    Stock-Based Compensation
    		 160K 71K 397K
    Other Working Capital
    		 84K 149K 2.19M
    Other Non-Cash Items
    		 -437K -445K -144K
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 -64K 176K 1.98M
    Operating Cash Flow
    		 -1.52M -1.74M -218K
    Capital Expenditures
    		 n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -18.59M n/a n/a
    Sales Maturities Of Investments
    		 6M n/a n/a
    Other Investing Acitivies
    		 139K 445K 144K
    Investing Cash Flow
    		 -12.45M 445K 144K
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 521K 6.53M 239K
    Financial Cash Flow
    		 521K 6.53M 239K
    Net Cash Flow
    		 -13.45M 5.24M 165K
    Free Cash Flow
    		 -1.52M -1.74M -218K

    Add to Watchlist